- Q3 2024 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptFeb 01, 2024
- Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q2 2024 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptOct 26, 2023
- Takeda Pharmaceutical Co Ltd at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q1 2024 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptJul 27, 2023
- Full Year 2023 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptMay 11, 2023
- Takeda Pharmaceutical Co Ltd TAK-279 on Phase 2b Psoriasis Investor Call TranscriptMar 18, 2023
- Takeda Pharmaceutical Co Ltd QDENGA Investor Call TranscriptMar 15, 2023
- Takeda Pharmaceutical Co Ltd at Cowen Health Care Conference TranscriptMar 06, 2023
- Q3 2023 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptFeb 02, 2023
- Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Takeda Pharmaceutical Co Ltd to Acquire Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics Call TranscriptDec 13, 2022
- Q2 2023 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptOct 27, 2022
- Takeda Pharmaceutical Co Ltd Lysosomal Storage Diseases Investor Seminar TranscriptOct 04, 2022
- Takeda Pharmaceutical Co Ltd at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q1 2023 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptJul 28, 2022€37.59Earnings
- Full Year 2022 Takeda Pharmaceutical Co Ltd Earnings Presentation (Q&A) TranscriptMay 11, 2022
- Full Year 2022 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptMay 11, 2022
- Takeda Pharmaceutical Co Ltd at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Q3 2022 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptFeb 03, 2022€37.59Earnings
- Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Takeda Pharmaceutical Co Ltd Management Call TranscriptJan 10, 2022
- Takeda Pharmaceutical Co Ltd Plasma-Derived Therapies Investor Event Presentation (Japanese) TranscriptNov 17, 2021
- Q2 2022 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptOct 28, 2021€37.59Earnings
- Q2 2022 Takeda Pharmaceutical Co Ltd Earnings Press Conference TranscriptOct 28, 2021
- Calithera Biosciences Inc to Acquire Assets From Takeda Pharmaceutical Co Ltd Call TranscriptOct 18, 2021
- Q1 2022 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptJul 30, 2021€37.59Earnings
- Takeda Pharmaceutical Co Ltd Finance Investor Day TranscriptJul 12, 2021
- Takeda Pharmaceutical Co Ltd Oncology Strategic Update Call TranscriptJun 08, 2021
- Full Year 2021 Takeda Pharmaceutical Co Ltd Earnings Call - Q&A Session TranscriptMay 11, 2021€37.59Earnings
- Full Year 2021 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptMay 11, 2021€37.59Earnings
- Full Year 2021 Takeda Pharmaceutical Co Ltd Earnings Press Conference TranscriptMay 11, 2021
- Takeda Pharmaceutical Co Ltd Wave 1 Pipeline Opportunity Call - Part 2 - R&D Team Follow Up Call TranscriptApr 21, 2021
- Takeda Pharmaceutical Co Ltd Wave 1 Pipeline Opportunity Call - Part 2 TranscriptApr 06, 2021
- Takeda Pharmaceutical Co Ltd Growth & Emerging Markets Strategic Update Call TranscriptMar 11, 2021
- Ovid Therapeutics Inc and Takeda Pharmaceutical Co Ltd to Discuss Strategic Transaction Call TranscriptMar 03, 2021
- Takeda Pharmaceutical Co Ltd Oncology Business Investor and Analyst Seminar TranscriptFeb 25, 2021
- Q3 2021 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptFeb 04, 2021€37.59Earnings
- Takeda Pharmaceutical Co Ltd World Conference on Lung Cancer (WCLC) Investor Call TranscriptJan 29, 2021
- Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Takeda Pharmaceutical Co Ltd Wave 1 Pipeline Market Opportunity Call TranscriptDec 08, 2020
- Q2 2021 Takeda Pharmaceutical Co Ltd Earnings Call - Q&A Session TranscriptOct 29, 2020€37.59Earnings
- Q2 2021 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptOct 29, 2020€37.59Earnings
- Arrowhead Pharmaceuticals Inc and Takeda Pharmaceutical Co Ltd Collaboration and Licensing Agreement to Develop ARO-AAT Conference Call TranscriptOct 08, 2020
- Ovid Therapeutics Inc. - Special Call TranscriptAug 25, 2020
- Q1 2021 Takeda Pharmaceutical Co Ltd Earnings Call - Q&A Session TranscriptJul 31, 2020€37.59Earnings
- Q1 2021 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptJul 31, 2020€37.59Earnings
- Neurocrine Biosciences Inc and Takeda Pharmaceutical Co Ltd Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders TranscriptJun 16, 2020
- Takeda Pharmaceutical Co Ltd Oncology Focused Investor Call TranscriptJun 08, 2020
- Takeda Pharmaceutical Co Ltd at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- Full Year 2020 Takeda Pharmaceutical Co Ltd Earnings Call - Q&A Session TranscriptMay 13, 2020€37.59Earnings
- Full Year 2020 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptMay 13, 2020€37.59Earnings
- Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Call - Q&A Session TranscriptFeb 04, 2020€37.59Earnings
- Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptFeb 04, 2020€37.59Earnings
- Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Takeda Pharmaceutical Co Ltd R&D and Plasma-Derived Therapies Day - Tokyo TranscriptNov 21, 2019
- Takeda Pharmaceutical Co Ltd Plasma-Derived Therapies Day - Georgia TranscriptNov 15, 2019
- Takeda Pharmaceutical Co Ltd R&D Day - New York TranscriptNov 14, 2019
- Q2 2020 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptOct 31, 2019€37.59Earnings
- Q2 2020 Takeda Pharmaceutical Co Ltd Earnings Presentation TranscriptOct 31, 2019
- Takeda Pharmaceutical Co Ltd Plasma-Derived Therapies Business Investor Meeting TranscriptOct 10, 2019
- Takeda Pharmaceutical Co Ltd at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q1 2020 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptJul 31, 2019€37.59Earnings
- Full Year 2019 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptMay 14, 2019€37.59Earnings
- Full Year 2019 Takeda Pharmaceutical Co Ltd Earnings Call TranscriptMay 14, 2019€37.59Earnings
- Novartis AG to Discuss Acquisition of Xiidra® from Takeda Pharmaceutical Co Ltd Call TranscriptMay 09, 2019
Takeda Pharmaceutical Co Ltd TAK-279 on Phase 2b Psoriasis Investor Call Transcript
Yes. Thank you very much, Chris, and welcome, everybody. Thank you for joining us at such an odd hour, Saturday night for those here in the U.S. and Sunday morning in Japan. And thank you for taking
(technical difficulty)
Yes. Can you hear me now, Chris? Terrific. I was just highlighting that we are coming off of an incredibly successful 2022 for Takeda R&D with really terrific momentum. I just wanted to share a few of the highlights.
Our dengue vaccine, QDENGA, was approved in Europe and in a number of endemic countries. And we had our filing at the FDA accepted. We had 3 Phase III study readouts that came out quite successfully: TAK-755 in TTP; ENTYVIO for graft versus host disease, where we just presented data at ECCO, very well-received; and the compound, the VEGF receptor inhibitor, that we just acquired ex-China rights from HUTCHMED, fruquintinib, which is approaching filing in the U.S. very shortly.
And then our mid- to late-stage
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)